Pulmonary arterial hypertension – progress in understanding the disease and prioritizing strategies for drug development
Pavandeep Ghataorhe(GlaxoSmithKline (United Kingdom)), Martin R. Wilkins(Hammersmith Hospital), Christopher J. Rhodes(Centre for Human Genetics), John Wharton(Pfizer (United Kingdom)), Lars Harbaum(Universität Hamburg), Mark Attard(Imperial College London)
Cited by 28
Related Papers
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784
Regulation of Endothelial Constitutive Nitric Oxide Synthase Gene Expression in Endothelial Cells and In Vivo
|Circulation|2000|631
Basic Science of Pulmonary Arterial Hypertension for Clinicians
|Circulation|2010|488